Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Sonoma Pharmaceuticals, Inc.

NASDAQ: SNOAHealthcare / Drug Manufacturers - Other / USA
0.78+0.03+4.00%Vol 397 4811Y Perf -83.62%
Dec 10th, 2018 11:45
BID0.78 ASK0.80
Open0.76 Previous Close0.75
Pre-Market- After-Trading-
 - -%  - -%
Target Price
5.00 
Analyst Rating
Moderate Buy 1.67
Potencial %
532.91 
Finscreener Ranking
★★★★+     59.90
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
★★★★     57.05
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
★★     46.35
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)5 
Earnings Rating
Neutral
Price Range Ratio 52wk %
1.15 
Earnings Date
8th Nov 2018

Today's Price Range

0.750.85

 

52wk Range

0.725.92

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Month
-43.08%
3 Months
-60.00%
6 Months
-80.58%
1 Year
-83.62%
3 Years
-87.13%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
SNOA0.780.03004.00
AAPL165.05-3.4400-2.04
GOOG1 035.56-1.0200-0.10
MSFT104.990.17000.16
XOM75.18-2.4600-3.17
WFC48.62-1.6400-3.26
JNJ143.07-2.3600-1.62
FB140.733.31002.41
GE6.86-0.1500-2.14
JPM100.15-3.1400-3.04
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
2.30
Current Ratio
3.80
Long Term Debt to Total Capital
0.01
Total Debt to Equity
0.03
Interest Coverage
-363.80
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
44.10
EBIT Margin
-79.70
EBITDA Margin
-77.00
Pre-tax Profit Margin
-75.20
Profit Margin
-79.91
ValuationValueIndustryS&P 500US Markets
PE Ratio
2.70
PB Ratio
0.83
PS Ratios
0.50
Price to Cash Flow
10.50
Price to Free Cash Flow
-0.80
Cash Flow Per Share
-2.13
Price to Tangible Book
0.83
Book Value per Share
0.97
Enterprise Value (in ths.)
5 257
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-30.10
ROE last 12 Months
-105.61
Return on Assets (5Y Avg)
-22.82
ROA last 12 Months
-82.48
Return on Capital (5Y Avg)
-24.99
ROC last 12 Months
-104.50
Return on invested Capital Q
-23.63
Return on invested Capital Y
-77.13
Assets Turnover
0.30
Receivables Turnover
2.80
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
17 806
Revenue per Share
1.60
Revenue Growth 3 Years
4.70
Revenue Growth 5 Years
4.41
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q02 2019--0.44-
Q01 2019--0.55-
Q04 2018-0.65-0.93-43.08
Q03 2018-0.63-0.73-15.87
Q02 2018-0.75-0.6710.67
Q01 2017--0.61-
Q04 2016--0.16-
Q03 2016--0.19-
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.2189.50Positive
3/2019 QR-0.20--
3/2019 FY-2.00--
3/2019 FY-2.200.00-
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume397 481
Shares Outstanding (in ths.)6 590
Trades Count761
Dollar Volume305 669
Avg. Volume129 504
Avg. Weekly Volume176 302
Avg. Monthly Volume508 491
Avg. Quarterly Volume247 778

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

69%31%

Bearish Bullish

68%32%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.67
Moderate Buy
1.67
Moderate Buy
1.67

There are no comments yet.

News